Chun-Lin Zhang (Chunlin Zhang, Zhang Chun-Lin)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Anterior Cruciate Ligament Reconstruction

Prognostic Factors

Long Noncoding Rna

Artificial Intelligence

Top Venues

Clinical and translational medicine

Drug development research

Cell death discovery

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Yongjie Wang, Xiaolong Ma, Enjie Xu, Zhen Huang, Chen Yang, Kun-Peng Zhu, Yang Dong, Chun-Lin Zhang
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clinical and translational medicine 14 (2) (2024)
Yongjie Wang, Xiaolong Ma, Enjie Xu, Zhen Huang, Chen Yang, Kun-Peng Zhu, Yang Dong, Chun-Lin Zhang
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clinical and translational medicine 14 (2) (2024)
Yongjie Wang, Xiaolong Ma, Enjie Xu, Zhen Huang, Chen Yang, Kun-Peng Zhu, Yang Dong, Chun-Lin Zhang
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clinical and translational medicine 14 (2) (2024)
Yongjie Wang, Xiaolong Ma, Enjie Xu, Zhen Huang, Chen Yang, Kun-Peng Zhu, Yang Dong, Chun-Lin Zhang
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clinical and translational medicine 14 (2) (2024)
Zhen Huang, Chun-Lin Zhang, Kunpeng Zhu, Jianping Hu, Enjie Xu, Xiaolong Ma, Yongjie Wang, Yurun Zhu, Jiazhuang Zhu
(E)-SIS3 suppressed osteosarcoma progression via promoting cell apoptosis, arresting cell cycle, and regulating the tumor immune microenvironment. Drug development research (2023)
Chun-Lin Zhang, Jianping Hu, Yingying Jiang, Shuo Tan, Kunpeng Zhu, Chao Xue, Yulun Dai, Feng Chen
Biomineralization-inspired synthesis of amorphous manganese phosphates for GLUT5-targeted drug-free catalytic therapy of osteosarcoma. Nanoscale 14 (3) (2022)
Xiao-Long Ma, Tai-Cheng Zhan, Jian-Ping Hu, Chun-Lin Zhang, Kun-Peng Zhu
Doxorubicin-induced novel circRNA_0004674 facilitates osteosarcoma progression and chemoresistance by upregulating MCL1 through miR-142-5p. Cell death discovery 7 (1) (2021)
Jianping Hu, Chun-Lin Zhang, Kunpeng Zhu, Lei Zhang, Tao Cai, Taicheng Zhan, Xiong Luo
Treatment-Related Prognostic Factors in Managing Osteosarcoma around the Knee with Limb Salvage Surgery: A Lesson from a Long-Term Follow-Up Study. BioMed research international 2019 (2019)
Zhu Kun-Peng, Chun-Lin Zhang, Ma Xiao-Long, Zhang Lei
Fibronectin-1 modulated by the long noncoding RNA OIP5-AS1/miR-200b-3p axis contributes to doxorubicin resistance of osteosarcoma cells. Journal of cellular physiology 234 (5) (2018)